Abivax

Company in Paris, France

Last price

—

Floor price

—

7-day median

—

30-day sales

30-day range

—

In circulation

Price history

Show table

Date	median	Low	High	sales

Sales history

Last sale: —
30-day average: —
30-day low: —
30-day high: —
Sales 7d: 0
Sales 30d: 0

No sales yet.

Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.

From Wikipedia

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod (formerly ABX464), to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Text: Wikipédia, CC BY-SA 4.0. ·

Related cards